# OnCo record nct07005154 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07005154/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07005154", "NCT07005154" ;
  schema:name "A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer"@en ;
  schema:description "A phase 2 trial of Prednisone, Abiraterone acetate in prostate cancer, run by Astellas Pharma Global Development, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07005154/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07005154> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-08-19" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/abiraterone/> ;
  onco:companies <https://onco.cc/companies/astellas/> .